4//SEC Filing
Magnani John L. 4
Accession 0001209191-22-017977
CIK 0001253689other
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 5:06 PM ET
Size
6.3 KB
Accession
0001209191-22-017977
Insider Transaction Report
Form 4
Magnani John L.
DirectorVP of Research, CSO
Transactions
- Sale
Common Stock
2022-03-09$1.09/sh−3,227$3,517→ 321,033 total
Holdings
- 4,845(indirect: By GlycoTech Corporation)
Common Stock
Footnotes (3)
- [F1]The sales reported on this Form 4 were effected to satisfy tax withholding obligations in connection with the settlement of restricted stock units as part of a "sell to cover" transaction and do not represent discretionary trades by the reporting person.
- [F2]The common stock was sold by the reporting person in a series of open market transactions on the transaction date with a volume weighted average sale price of $1.09. The range of sales prices for the transactions reported was $1.09 to $1.10 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]These shares are held by GlycoTech Corporation, of which the reporting person is the sole stockholder.
Documents
Issuer
GLYCOMIMETICS INC
CIK 0001253689
Entity typeother
Related Parties
1- filerCIK 0001589713
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 7:00 PM ET
- Accepted
- Mar 10, 5:06 PM ET
- Size
- 6.3 KB